chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Can't raise that arm to use bands or wieghts; Losing function of that muscle; Left deltoid where she received both injections started hurting; Lower back ache; Couldn't sleep; Could hardly move; Felt Achy; Chills; Headache; Felt generally lousy; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Can't raise that arm to use bands or wieghts), INSOMNIA (Couldn't sleep), MUSCLE DISORDER (Losing function of that muscle), BACK PAIN (Lower back ache) and FEELING ABNORMAL (Felt generally lousy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder and Allergy.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced FEELING ABNORMAL (Felt generally lousy), MYALGIA (Felt Achy), CHILLS (Chills) and HEADACHE (Headache). On 20-Feb-2021, the patient experienced INSOMNIA (Couldn't sleep), BACK PAIN (Lower back ache) and HYPOKINESIA (Could hardly move). On an unknown date, the patient experienced MOBILITY DECREASED (Can't raise that arm to use bands or wieghts), MUSCLE DISORDER (Losing function of that muscle) and VACCINATION SITE PAIN (Left deltoid where she received both injections started hurting). On 17-Feb-2021, FEELING ABNORMAL (Felt generally lousy), MYALGIA (Felt Achy), CHILLS (Chills) and HEADACHE (Headache) had resolved. On 21-Feb-2021, INSOMNIA (Couldn't sleep) had resolved. At the time of the report, MOBILITY DECREASED (Can't raise that arm to use bands or wieghts), MUSCLE DISORDER (Losing function of that muscle), BACK PAIN (Lower back ache) and VACCINATION SITE PAIN (Left deltoid where she received both injections started hurting) had not resolved and HYPOKINESIA (Could hardly move) outcome was unknown.            Concomitant medications used by the patient included, thyroid and allergy medications.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: New events updated in follow up. On 04-Jun-2021: New events updated in follow up.
Bleeding, Fever & Diarrhea Narrative: 2nd Covid vaccination on 01-26-21. C/o diarrhea, sore left arm, fever, nose bleed on 1-27 and 1-28-21. States had the same reactions as when took the 1st dose. Returned to work today.
PATIENT RECEIVED  FLU VACCINE ON 09/02/2023  AND  CAME BACK  TO RECEIVE SHINGRIX BUT WAS GIVEN ANOTHER FLU SHOT. THE ERROR WAS DISCOVERED AND THE PATIENT WAS CONTACTED TO REPORT ANY SYMPTOMS.
Initial and follow up information was received from a nurse practitioner via company representative, regarding on a 26 year old female patient. Patient's medical history or concurrent conditions were not provided. On 04-AUG-2015, the patient was vaccinated with the first dose of GARDASIL 9, intramuscular (strength, lot number and expiration date not provided). There was no concomitant therapies reported. On 04-AUG-2015, the patient tired and drained few hours after the vaccination with GARDASIL 9. Then, 6 to 8 hours after vaccination, loss of appetite and body aches, 12 to 14 hours later, the patient felt headache and had a sore throat. It was reported that when the patient woke up, the morning of this report (05-AUG-2015), her condition had worsened. The patient contacted the nurse practitioner, and was advised to go to Emergency Room (ER) for treatment. It was unspecified whether the patient was admitted to the hospital from the unspecified emergency room. It was unspecified whether the patient intended to continue GARDASIL 9 series, due to these adverse effects. The relationship between decreased appetite, asthenia, fatigue, headache and oropharyngeal pain with GARDASIL 9 was unknown. Additional information has been requested.
Pt received vaccine at approximately 2:00pm, within several hours pt began shaking uncontrollably with chills, could barely talk or dial phone, did not have a fever at that time. Shivering continued for several more hours then pt developed a fever of 102, pt took tylenol, vomited, and continued shivering until approximately 12:30am. Two days later these symptoms resolved except soreness at injection site.
Father and child returned to clinic with concern reporting that 1/2hr after vaccination that child dropped to floor, started screaming, arching back, and tightening up. This would repeat about every half hour. No redness or swelling at site. No seizures. Instructed to call doctor and report above. Planned to call them 3/15/13. 3/15/13 p.c. 10:00 am to mother. Doctor had been called and had advised to watch him until 3/15/13 and if still same to report back. Dr thought it was possibly d.t. pain associated with very first shot. Mother reported child is better today and that her concern is resolving.
Itching-started 11/2/07 approx. 8 or 9pm.  Hives-when woke up Sat. 11/3/07 on arms, head, shoulder & back.  Seen by Dr.
pt recv vax 17MAY96 & 26MAY96 pt devel a rash, described as a few raised bumps, @ inj site;a few days later pt devel a fever of about 104;the fever was alleviated w/Ibuprofen;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 27-OCT-2014 the patient was vaccinated with an expired dose of M-M-R II (lot# reported as H018945, expiration date reported as 18-OCT-2014, dose, dose number and route unspecified). No adverse effect reported. The outcome of the event was not reported. No product quality complaint (PQC) involved. Additional information has been requested.
pt recvd vax & exp burning @ inject site during vax w/Hep B vax;
For approximately 36 hours everything I looked at appeared to look like I was watching a 3D movie without the glasses.  Once those symptoms subsided, my vision has been permanently blurry.  I always had 20/20 vision.  My last eye exam was in March of 2020.  At which time, I had perfect vision.  I scheduled an optometry appointment after the event.  My optic nerves are enlarged and I now need correction for both near and far.
sensation in eye; tingling lips; numbness in chin; numbness in face; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (tingling lips), HYPOAESTHESIA (numbness in chin), HYPOAESTHESIA (numbness in face) and OCULAR DISCOMFORT (sensation in eye) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included PARACETAMOL (TYLENOL).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PARAESTHESIA ORAL (tingling lips), HYPOAESTHESIA (numbness in chin) and HYPOAESTHESIA (numbness in face). On 29-Jan-2021, the patient experienced OCULAR DISCOMFORT (sensation in eye). At the time of the report, PARAESTHESIA ORAL (tingling lips), HYPOAESTHESIA (numbness in chin), HYPOAESTHESIA (numbness in face) and OCULAR DISCOMFORT (sensation in eye) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
This study case was received from the investigator on 28 October 2011. A 37 year-old male subject was found to have an Prinzmetal angina 27 days after he had received on 02 September 2011 an injection of ACAM2000 (lot number, route and site of administration not reported). Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 03.10 on 17 September 2011 and an abnormal ECG on 15 September 2011. The subject's echocardiogram was not available. A lumbar puncture and MRI of the brain, spinal cord and heart rate were not performed. Treatments were not reported. The subject's outcome was not reported. There is no reporter causality assessment as this is a safety surveillance study. Documents held by sender: None.
Very tired and sore-like been hit by a truck--very very weak--lasted 24 hours-- I slept for about 20 hours
LOW GRADE FEVER; EXTREME EXHAUSTION; ACHE AND PAIN ALL OVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 16:15 to Right Arm for prophylactic vaccination. No concomitant medications were reported.  On 11-MAR-2021, the subject experienced low grade fever. On 11-MAR-2021, the subject experienced extreme exhaustion. On 11-MAR-2021, the subject experienced ache and pain all over. Laboratory data included: Body temperature (NR: not provided) 99 degrees. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, extreme exhaustion, and ache and pain all over on 12-MAR-2021. This report was non-serious.
migraine headache; A report was received from a consumers husband concerning a  67 years old, Female patient was participating in the mRNA-1273 Emergency Use Program and developed/experienced  migraine headache.  Medical history not provided by reporter. Relevant concomitant medications were not reported.  On [02Feb2021 ], the patient received their second of two planned doses of mRNA-1273 in  the [Left arm] for prophylaxis of COVID-19 infection.    While participating in this program, and preceding this event, the patient experienced the adverse event(s) of special interest of [Migraine headache)If it is known that the event occurred after the second dose of mRNA-1273 on 03Feb2021.  No treatment information was provided, the reporter wants to know if his wife can take Relpax, her migraine .   The patient received both scheduled doses of mRNA-1273 prior to the event(s), therefore action taken with the drug in response to the event(s) is not applicable.   The outcome of the event, MIigraine headache was unknown.; Reporter's Comments: Based on the current available information which includes a strong temporal association between the use of the product and the start date of the reported event, a causal relationship with the event cannot be excluded.
I had a skin rash on my wrists and inside my elbows on both arms, also around my waist.  When I received my second dose the rashes disappeared in a day.
i had chest pains dizziness shortness of breath seeing stars feeling like i would pass out.  i tried to drive myself to the hospital but i had to pull over on the way and rest in my car or a couple of hours.  i was very sick or 24 hours.  i felt like i was having a heart attack or stroke.
patient received pneumovax23 and reported complete arm paralysis 3 hours after the immunization
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 13 year-old male patient received bnt162b2 (COMIRNATY), administration date 17Jun2021 (Batch/Lot number: unknown) as dose 2, single for Covid-19 immunisation. Relevant medical history included: "Mild asthma" (unspecified if ongoing), notes: Verbatim: Mild asthma; "Peanut allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer- unknown, Dose no: 1), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 30Jan2022, outcome "unknown", described as "Headache"; NAUSEA (non-serious) with onset 30Jan2022, outcome "unknown", described as "Nausea"; OROPHARYNGEAL PAIN (non-serious) with onset 30Jan2022, outcome "unknown", described as "Sore throat". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Reporter Contact Information: Reporter was a minor or child. Description of Event: (withheld) was a 13 year old boy. Pt received second dose of Comirnaty on 17Jun2021. (withheld) began experiencing a headache and nausea and sore throat on 30Jan2022. He tested positive on rapid antigen test on 31Jan2022. Name of Product: Comirnaty. Awareness Date: 31Jan2022. Event took place after use of product. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day 1 - headache Day 2 - vomiting all day, terrible headache, chills, sweats (no fever when checked) fatigue Day 3 - severe headache, nausea, chills, sweats (no fever when checked) fatigue Day 4 - headache nausea fatigue Day 5 - headache nausea fatigue Day 6 - headache nausea fatigue diarrhea  Day 7 - headache nausea fatigue diarrhea  Day 8 - headache nausea fatigue
Large 2-3 inch in diameter hard knot at injection site, hot to the touch and very itchy
Onset of rash 2/9/15 on torso. Rash spread to face, neck, buttocks and legs 2/10/15.
Systemic rash - face, neck, arms - I took 4 zyrtec which finally stopped it from spreading
4 Days after vaccine (4/16/21), elevated heart rates while running/exercising.   Max HR was 195+ for 46/yo Male.   This continued during running for more 12 days (4/28/21), and seemed had resided on 4/29/21.   Note: Prior to vaccine only had two runs with a max HR higher than 190, both of those were strenuous endurance events (high altitude or sprinting).   10 Days after the high heart rates, on 5/10 patient experienced another spike in heart rates, and a few.  On 5/18 another high heart rate episode occurred but patient didn't see heart rate recover.    Patient utilized a new smart watch to check ECG and watch diagnosed they were in AFIB.  Patient visited doc / ER and while in ER came out of Afib, patient was placed on Metropol.    Patient back into Afib 1 week later, admitted to hospital to undergo Cardioversion.    Patient is still working with cardiologist and internist to determine next steps.
After receiving the vaccine , patient went in and out of unconsciousness for about 2 to 3 minutes. (like dozing on and off). He was also sweating as well. Emergency number was called and the emergency team of 2 came into the store to attend to him by which time he had regained consciousness and drank some bottled water provided by his father.   The emergency team took him away on a stretcher (he walked by himself to lie down on it).
Patient reports severe all-over body pain (10/10), headache, and fatigue starting seven hours after receiving influenza vaccination. Acetaminophen did not provide relief. Approximately 48 hours after receiving the vaccination all symptoms except headache had resolved. Intermittent headaches persisted for at least two weeks after receiving vaccination.
itching in hand on arm that she got shot in; swelling in her hand; This is a spontaneous report from a contactable consumer (the patient).  A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL3246, expiration date unknown), via an unknown route of administration (reported as "through a needle") in the left arm, on 18Jan2021 (at the age of 67-years-old) at an unspecified dose for COVID-19 vaccination.  The patient's medical history was not reported. The patient was administered the vaccine in the Health Department. The patient's concomitant medications were not reported. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 19Jan2021 (reported as "last night") the patient experienced itching in hand on the arm that she got the shot in. She stated that she is experiencing swelling in her left hand as well.  The patient described further that it is not itching as bad and stated that after the itching it swelled up. Treatment was reported as having taken Benadryl for the itching. The clinical outcomes of itching in hand was reported as recovering and the clinical outcome of swelling in hand was reported as not recovered.
Nausea 8/9/2021 1900 Dizziness 8/10/2021 0515 all day Fainting 8/10/2021 0515 one occurrence
Dates of 4 vaccinations with mRNA, LNP-S, PF, 100 mcg/0.5 mL or 50 mcg/0.25 mL per TennIIS: 03/22/2021, 04/22/2021; 12/17/2021; 05/20/2022
mom stated pt devel a rash 330PM which became raised-pt seemed to have some difficulty breathing & it was hard keeping pt awake; pt was given DPH in ER:
Mom states one day post vax, the child's arm swelled up and was sore. She applied cool compresses and gave Tylenol. This all went away the next day. On 4/13/01, the other arm had a blister almost like chicken pox. On 4/14/01, the pt's grandmother thought it looked infected but to wait until the pt saw the doctor. On 4/16/01 the pt saw a doctor and was placed on antibiotics. On 4/18/01 the pt went to the ER and was told by the ER MD it was a sterile pox, and no further treatment was needed.
Within 36hrs, experienced extreme abdominal pains on the left side of the abdomen; Within 12hrs of dose, experienced flu-like symptoms; Elevated body temperature (no fever); Aches; Headache; Nausea; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 02:00, within 12 hours of dose, the patient experienced flu-like symptoms with elevated body temperature (no fever), aches, headache, nausea, and fatigue. On 17Apr2021 at 01:00, within 36 hours, the patient experienced extreme abdominal pains on the left side of his abdomen, which passed within 12 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. On 16Apr2021 at 02:00, the patient underwent body temperature test and the result was increased. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events within 12 hours of dose, experienced flu-like symptoms, elevated body temperature (no fever), aches, headache, nausea and fatigue was resolved on an unknown date in Apr2021 while the event within 36 hours, experienced extreme abdominal pains on the left side of the abdomen was resolved on 17Apr2021 at 13:00.  No follow-up attempts are possible. No further information is expected.
Patient seen in the ED on 6/25 for shortness of breath with oxygen sats around 70's on room air. He was noted to have tested positive for COVID-19 a few days prior on 6/17. He was admitted to the hospital from 6/25-7/14 with severe sepsis, acute hypoxic respiratory failure, and recent COVID-19 infection. On 7/15, patient was found to be unresponsive and ultimately passed away in the hospital. Patient with medical history including dementia and metastatic cancer.
redness on lt arm @ inj site measuring 38mm x 36mm;warmth, mild swelling, mild pain & pruritus;;
The patient received her first dose of the Moderna Covid-19 vaccine on 1/2/2021. Shortly after she noted that her hand eczema significantly worsened and became more swollen and itchy. She was treated with oral steroids and antihistamines. She had her second dose of the Moderna Covid-19 vaccine on 1/30/2021. After her second dose she noticed a flare of her hand and face dermatitis. She then developed shingles on the right side of the face shortly after the second dose, which was treated with valacylovir and gabapentin.
I notice extremity SOB.  I talk to my doctor over the next two weeks.  My doctor had blood work done.  My D-dimer was 16 times higher than normal.  He also order CT scan on Dec 17th; which showed a bilateral pulmonary emboli and a portal clasped lung.
Chills, tiredness, muscle pain, nausea, red itchy left eyebrow with skin that flakes off, flu-like symptoms
Headache approximately 12 hours after lasting approximately 24 hours Spike in blood pressure (155/99 being highest recorded) about 18 hours after injection and current high blood pressure  Low grade fever within 12 hours of injection  lasting 48 hours
Case number PHEH2015US019175, is an initial spontaneous report from a nurse received on 28 Sep 2015. This report refers to a male patient of an unknown age. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515101) at a dose of 1 ml intramuscularly on 28 Sep 2015. No adverse event was reported.
I was having my normal mammogram and found a lump between the breast and underarm area. An ultrasound was completed and the lump was discovered. My doctor is currently monitoring it and indicated that if its still there at next mammogram then a biopsy will be necessary.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 27-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is on concomitant medications of blood pressure medication on regular basis. No treatment medications were mentioned.
Diffuse body aches upon awakening.  Temp at 4:00 PM 101.7F
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 01-JUN-2015, the patient was inoculated with ZOSTAVAX on a pharmacy as recommended for routine adult health maintenance for long-term prevention of shingles (strength, dose, dosage schedule, route, anatomical location, lot # and expiry date were not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about an unspecified date in September 2015, the patient was treated for a persistent and severe vesicular rash, which was diagnosed as severe herpes zoster or shingles. Later, on or about September 2015, the patient sought subsequently treatment in a dermatology facility for a persistent and severe vesicular rash, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The reporter considered the events to be related with ZOSTAVAX.